- Home
- TAK vs CCI Comparison
TAK vs CCI Comparison
Compare TAK & CCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TAK | CCI |
|---|---|---|
| Founded | 1781 | 1994 |
| Country | Japan | United States |
| Employees | 47455 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.1B | 39.4B |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | TAK | CCI |
|---|---|---|
| Price | $17.86 | $90.83 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 15 |
| Target Price | N/A | ★ $106.67 |
| AVG Volume (30 Days) | 2.4M | ★ 3.7M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | 2.97% | ★ 4.72% |
| EPS Growth | N/A | ★ 111.25 |
| EPS | N/A | ★ 1.01 |
| Revenue | N/A | ★ $4,264,000,000.00 |
| Revenue This Year | $0.04 | N/A |
| Revenue Next Year | $0.92 | $1.63 |
| P/E Ratio | ★ $41.25 | $89.42 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.99 | $77.89 |
| 52 Week High | $18.82 | $115.76 |
Technical Indicators
Market Signals| Indicator | TAK | CCI |
|---|---|---|
| Relative Strength Index (RSI) | 49.07 | 57.51 |
| Support Level | $14.78 | $87.44 |
| Resistance Level | $18.82 | $92.66 |
| Average True Range (ATR) | 0.24 | 2.59 |
| MACD | -0.18 | 0.40 |
| Stochastic Oscillator | 26.30 | 83.23 |
Price Performance
Historical ComparisonAbout TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
About CCI Crown Castle Inc.
Crown Castle owns or manages roughly 40,000 wireless towers in the United States. It leases space on its towers to wireless service providers, which install equipment to support their wireless networks. The company has a very concentrated customer base, with about 75% of its revenue from the Big Three US mobile carriers: Verizon, T-Mobile, and AT&T. Crown Castle has plans to divest its fiber business, which is expected to be finalized in the first half of 2026. After that, it will be a stand-alone tower operator. Crown Castle operates as a real estate investment trust.